A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells

Journal of Cell Science

Volumn 120, Issue 18, 2007, Pages 3219-3227

  Condemine, Wilfried ^a   Takahashi, Yuki ^a   Le Bras, Morgane ^a   de Thé, Hugues ^a  

^a CNRS   (France)

Author keywords

Isoforms; Nucleolus; PML; Proteasome; Senescence; Stress; Ubiquitin

Indexed keywords

EXODEOXYRIBONUCLEASE III; ISOPROTEIN; POLYUBIQUITIN; PROMYELOCYTIC LEUKEMIA PROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL AGING; CELL COMPOSITION; CELL NUCLEUS INCLUSION BODY; CELL ORGANELLE; CELL STRESS; CONJUGATE; CONTROLLED STUDY; EMBRYO; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOLUS; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN TARGETING; PROTEIN VARIANT; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL AGING; CELL LINE, TUMOR; CELL NUCLEOLUS; EXODEOXYRIBONUCLEASES; HUMANS; INTRANUCLEAR INCLUSION BODIES; MICE; NEOPLASM PROTEINS; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PROTEINS; PROTEIN FOLDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; SKIN NEOPLASMS; STRESS; STRUCTURAL HOMOLOGY, PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN;

EID: 35548950835     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.007492     Document Type: Article

References (49)

1. Anton, L. C., Schubert, U., Bacik, I., Princiotta, M. F., Wearsch, P. A., Gibbs, J., Day, P., Realini, C., Rechsteiner, M., Bennink, J. et al. (1999). Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol. 146, 113-124.
2. Bernardi, R., Scaglioni, P. P., Bergmann, S., Horn, H. F., Vousden, K. H. and Pandolfi, P. P. (2004). PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat. Cell Biol. 6, 665-672.
3. Bischof, O., Kirsh, O., Pearson, M., Itahana, K., Pelicci, P. G. and Dejean, A. (2002). Deconstructing PML-induced premature senescence. EMBO J. 121, 3358-3369.
4. Boe, S. O., Haave, M., Jul-Larsen, A., Grudic, A., Bjerkvig, R. and Lonning, P. E. (2006). Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA. J. Cell Sci. 119, 3284-3295.
5. Borden, K. L. (2002). Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22, 5259-5269.
6. Condemine, W., Takahashi, Y., Zhu, J., Puvion-Dutilleul, F., Guegan, S., Janin, A. and de The, H. (2006). Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res. 66, 6192-6198.
7. Daniel, M.-T., Koken, M., Romagné, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M.-C., Degos, L., Chomienne, C. and de Thé, H. (1993). PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82, 1858-1867.
8. de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. (1991). The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684.
9. Dellaire, G. and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26, 963-977.
10. Dellaire, G., Ching, R. W., Dehghani, H., Ren, Y. and Bazett-Jones, D. P. (2006). The number of PML nuclear bodies increases in early S phase by a fission mechanism. J. Cell Sci. 119, 1026-1033.
11. Eskiw, C. H., Dellaire, G., Mymryk, J. S. and Bazett-Jones, D. P. (2003). Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. J. Cell Sci. 116, 4455-4466.
12. Everett, R. D. (2000). ICPO induces the accumulation of colocalizing conjugated ubiquitin. J. Virol. 74, 9994-10005.
13. Everett, R. D. (2006). Interactions between DNA viruses, NDIO and the DNA damage response. Cell. Microbiol. 8, 365-374.
14. Fogal, V., Gostissa, M., Sandy, P., Zacchi, P., Sternsdorf, T., Jensen, K., Pandolfi, P. P., Will, H., Schneider, C. and Del Sal, G. (2000). Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19, 6185-6195.
15. Gong, L. and Yeh, E. T. (2006). Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J. Biol. Chem. 281, 15869-15877.
16. Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Gu, W. and Paolo Pandolfi, P. (2000). The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2, 730-736.
17. Henderson, B. R. and Eleftheriou, A. (2000). A comparison of the activity, sequence specificity, and CRM1 -dependence of different nuclear export signals. Exp. Cell Res. 256, 213-224.
18. Henson, J. D., Neumann, A. A., Yeager, T. R. and Reddel, R. R. (2002). Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610.
19. Hoeller, D., Crosetto, N., Blagoev, B., Raiborg, C., Tikkanen, R., Wagner, S., Kowanetz, K., Breitling, R., Mann, M., Stenmark, H. and Dikic, I. (2006) Regulation of ubiquitin-binding proteins by monoubiquitination. Nat. Cell Biol. 8, 163-169
20. Jensen, K., Shiels, C. and Freemont, P. S. (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20, 7223-7233.
21. Jiang, W. Q. and Ringertz, N. (1997). Altered distribution of the promyelocytic leukemia-associated protein is associated with cellular senescence. Cell Growth Differ. 8, 513-522.
22. Jiang, W.-Q., Szekely, L., Klein, G. and Ringertz, N. (1996). Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line. Exp. Cell Res. 229, 289-300.
23. Koken, M. H. M., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C. et al. (1994). The t(15;17) translocation alters a nuclear body in a RA-reversible fashion. EMBO J. 13, 1073-1083.
24. Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T. M., Ojala, P. M., Meek, D. and Laiho, M. (2004). Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5, 465-475.
25. Lafarga, M., Berciano, M. T., Pena, E., Mayo, I., Castano, J. G., Bohmann, D, Rodrigues, J. P., Tavanez, J. P. and Carmo-Fonseca, M. (2002). Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome. Mol. Biol. Cell 13, 2771-2782.
26. Lain, S., Midgley, C., Sparks, A., Lane, E. B. and Lane, D. P. (1999). An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp. Cell Res. 248, 457-472.
27. Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honore, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P. et al. (2001). Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As(2)O(3)-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med 193, 1361-1372.
28. LaMorte, V. J., Dyck, J. A., Ochs, R. L. and Evans, R. M. (1998). Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95, 4991-4996.
29. Luciani, J. J., Depetris, D., Usson, Y., Metzler-Guillemain, C., Mignon-Ravix, C., Mitchell, M. J., Megarbane, A., Sarda, P., Sirma, H., Moncla, A. et al. (2006). PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J. Cell Sci. 119, 2518-2531.
30. Mattsson, K., Pokrovskaja, K., Kiss, C., Klein, G. and Szekely, L. (2001). Proteins associated with the promyelocy(ic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc. Natl. Acad Sci. USA 98, 1012-1017.
31. Maul, G. G., Negorev, D., Bell, P. and Ishov, A. M. (2000). Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129, 278-287.
32. Meroni, G. and Diez-Roux, G. (2005). TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. BioEssays 27, 1147-1157.
33. Morency, E., Coute, Y., Thomas, J., Texier, P. and Lomonte, P. (2005). The protein ICP0 of herpes simplex virus type 1 is targeted to nucleoli of infected cells. Brief report. Arch. Virol. 150, 2387-2395.
34. Nabetani, A., Yokoyama, O. and Ishikawa, F. (2004). Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body. J. Biol. Chem. 279, 25849-25857.
35. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P. et al. (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-210.
36. Politz, J. C., Polena, I., Trask, I., Bazett-Jones, D. P. and Pederson, T. (2005). A nonribosomal landscape in the nucleolus revealed by the stem cell protein nucleostemin. Mol. Biol. Cell 16, 3401-3410.
37. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S. et al. (2001). The tripartite motif family identifies cell compartments. EMBO J. 20, 2140-2151.
38. Rokaeus, N., Klein, G., Wiman, K. G., Szekely, L. and Mattsson, K. (2006). PRIMA-1(MET) induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins. Oncogene 26, 982-992.
39. Salomoni, P. and Pandolfi, P. P. (2002). The role of PML in tumor suppression. Cell 108, 165-170.
40. Scaglioni, P. F., Yung, T., Cai, L. F., Erdjument-Bromage, H., Kaufman, A., Singh, B., Teruya-Feldstein, J., Tempst, P. and Pandolfi, P. P. (2006). A CK2-dependent pathway for PML degradation upon cellular and oncogenic stress. Cell 126, 269-283.
41. Seker, H., Rubbi, C., Linke, S. P., Bowman, E. D., Garfield, S., Hansen, L., Borden, K. L., Milner, J. and Harris, C. C. (2003). UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML. Oncogene 22, 1620-1628.
42. Shav-Tal, Y., Blechman, J., Darzacq, X., Montagna, C., Dye, B. T., Patton, J. G., Singer, R. H. and Zipori, D. (2005). Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition. Mol. Biol. Cell 16, 2395-2413.
43. Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M. and Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol. Cell 24, 331-339.
44. Short, K. M. and Cox, T. C. (2006). Subclassification of the RBCC/ TRlM superfamily reveals a novel motif necessary for microtubule binding. J. Biol. Chem. 281, 8970-8980.
45. Torres, C., Lewis, L. and Cristofalo, V. J. (2006). Proteasome inhibitors shorten replicative life span and induce a senescent-like phenotype of human fibroblasts. J. Cell. Physiol. 207, 845-853.
46. Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y. and Inoue, S. (2002). Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417, 871-875.
47. Wang, Z. G., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F. and Pandolfi, P. P. (1998). Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547-1551.
48. Wu, G., Lee, W. H. and Chen, P. L. (2000). NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275, 30618-30622.
49. Yeager, T. R., Neumann, A. A., Englezou, A., Huschtscha, L. I., Noble, J. R. and Reddel, R. R. (1999). Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179.